[{"id":"f7bd4c2c-3258-4ebe-a93d-4655b411ea4f","acronym":"","url":"https://clinicaltrials.gov/study/NCT04204161","created_at":"2021-01-18T20:28:53.736Z","updated_at":"2024-07-02T16:36:35.019Z","phase":"Phase 1","brief_title":"A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma","source_id_and_acronym":"NCT04204161","lead_sponsor":"Shenzhen BinDeBio Ltd.","biomarkers":" CD19 • CD22","pipe":" | ","alterations":" CD19 expression","tags":["CD19 • CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CAR-T19/CAR-T22 immunotherapy"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/08/2019","start_date":" 10/08/2019","primary_txt":" Primary completion: 10/30/2021","primary_completion_date":" 10/30/2021","study_txt":" Completion: 10/08/2024","study_completion_date":" 10/08/2024","last_update_posted":"2021-02-04"}]